Bo O. Xu
Jinhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Penehyclidine hydrochloride alleviates one-lung ventilation-induced lung injury by disrupting PLAT2-mediated glycerophospholipid metabolism and macrophage polarization.
Journal: International immunopharmacology
Published: November 27, 2025
ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non-small cell lung cancer.
Journal: The Journal of biological chemistry
Published: October 29, 2025
Lysine methylation-mediated SMYD2 degradation by casticin sensitizes non-small-cell lung cancer cells to osimertinib therapy.
Journal: Biochemical pharmacology
Published: September 10, 2025
METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4.
METTL14 plays an oncogenic role in NSCLC by modulating ferroptosis and the m6A modification of GPX4.
Journal: Archives of physiology and biochemistry
Published: July 12, 2024
Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via Spry4 upregulation-mediated ERK1/2 signaling inhibition.
Journal: Biochemical pharmacology
Published: March 21, 2024
Carbonic Anhydrase 4 Serves as A Novel Prognostic Biomarker and Therapeutic Target for Non-Small Cell Lung Cancer: A Study Based on TCGA Samples.
Journal: Combinatorial chemistry & high throughput screening
Published: November 25, 2022
Financial toxicity in patients with lung cancer: a scoping review protocol.
Journal: BMJ open
Published: May 25, 2022
A Novel Nonreciprocal/Reciprocal ALK Translocation Cause ALK+ in NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 12, 2021
Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua.
Journal: Molecular genetics & genomic medicine
Published: November 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026